EMA supports molnupiravir prior to formal authorisation
22nd November 2021 Uncategorised 0The oral antiviral drug is for the treatment of patients with COVID-19 More: EMA supports molnupiravir prior to formal authorisation Source: News
read moreThe oral antiviral drug is for the treatment of patients with COVID-19 More: EMA supports molnupiravir prior to formal authorisation Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals